Skip to main content
. 2020 Oct;9(5):1313–1327. doi: 10.21037/gs-20-366

Table 5. Postoperative pain, nausea, vomiting, and additional analgesic and antiemetic doses in patients undergoing MRM with and without immediate reconstruction.

MRM and immediate breast reconstruction (n=40) MRM alone (n=41) P value 95% confidence interval of the difference
Lower Upper
Pain (NPRS scale 0–10)
   1 h 7.0±1.2 4.8±2.2 0.001 −2.2 −0.98
   6 h 4.4±1.1 3.1±1.7 0.001 −1.40 −0.29
   12 h 2.7±0.9 1.8±1.2 0.001 −1.15 −0.28
   24 h 1.5±0.9 1±0.9 0.04 −0.78 −0.11
Nausea (%)
   1 h 20% 14.6% 0.52 0.96 1.0
   6 h 30% 24.4% 0.57 0.56 0.76
   12 h 30% 17.1% 0.17 0.05 0.19
   24 h 12.5% 7.3% 0.48 0.30 0.51
Vomiting (%)
   1 h 12.5% 2.4% 0.10 0.02 0.15
   6 h 17.5% 7.3% 0.19 0.10 0.27
   12 h 15% 4.9% 0.15 0.10 0.27
   24 h 5% 4.9% 0.61 0.96 1.0
Additional morphine doses (%)
   1 h 30% 14.6% 0.25 0.07 0.23
   6 h 20% 4.9% 0.04 0.02 0.13
   12 h 17.5% 2.4% 0.03 0.00 0.08
   24 h 5% 4.9% 0.98 0.96 1.0
Additional ondansetron doses (%)
   1 h 27.5% 14.6% 0.15 0.71 0.23
   6 h 37.5% 17.1% 0.04 0.00 0.08
   12 h 30% 14.6% 0.09 0.02 0.15
   24 h 12.5% 4.9% 0.26 0.09 0.25

Pain was recorded using a numeric pain rating scale (NPRS) from 0 to 10 based on patients’ perceived symptoms at the times of measurements. Values are expressed as means ± standard deviation. Nausea, vomiting, and additional drug doses are expressed as the percentages of patients who presented with these symptoms or required the drugs within the indicated time periods.